Sees FY24 Adjusted EBITDA $80M-$90M, and Center Margin $345M-$365M. Additionally, the Company expects to generate positive Free Cash Flow for the full year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LFST:
- LifeStance Health Group Shares Informative Investor Presentation
- LifeStance Reports Fourth Quarter and Full Year 2023 Results
- LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024
- LifeStance Health Resolves Litigation with Financial Settlement
- LifeStance tells Bloomberg short-seller report ‘designed to mislead investors’
